Management and predictors of clinical events in 75 686 patients with acute myocardial infarction.


Journal

Kardiologia polska
ISSN: 1897-4279
Titre abrégé: Kardiol Pol
Pays: Poland
ID NLM: 0376352

Informations de publication

Date de publication:
2022
Historique:
received: 21 02 2022
accepted: 21 02 2022
pubmed: 22 2 2022
medline: 4 5 2022
entrez: 21 2 2022
Statut: ppublish

Résumé

Although mortality in patients with acute myocardial infarction (MI) has decreased substantially over the last few decades in many countries, MI remains a major threat to public health. To assess the number and outcomes of patients hospitalized for acute MI in Poland in 2018 as well as proportions of patients participating in cardiac rehabilitation and undergoing invasive cardiac procedures following discharge. We used public databases. We included all patients hospitalized for acute MI in Poland in 2018 and assessed event-free survival along with uptake of invasive cardiac procedures, cardiac rehabilitation, and consultations with cardiologists. A total of 75868 patients (mean age, 68.8 years) were hospitalized for acute MI in Poland in 2018 (the admission rate, 197.0 per 100000 inhabitants). In-hospital mortality was 8.4%, while one-year mortality was 17.3% (one-year post-discharge mortality was 9.8%). Approximately 75% and 96% of discharged patients consulted a general practitioner, whereas 12% and 62% consulted a cardiologist, 5% and 19% underwent percutaneous coronary intervention, 0.6% and 2.9% un-derwent coronary artery bypass grafting, while 0.04% and 1.9% had an implantable cardioverter defibrillator implanted within 30 days and 365 days following discharge. The participation rate in cardiac rehabilitation within the first 14 days following discharge was 11%, within the first 30 days was 19%, and within 365 days was 35%. In-hospital and post-discharge mortality is still high in Poland. The access to cardiac consultations and cardiac rehabilitation following MI is insufficient. There is considerable potential for a further decrease in mortality in patients suffering from MI in Poland.

Sections du résumé

BACKGROUND
Although mortality in patients with acute myocardial infarction (MI) has decreased substantially over the last few decades in many countries, MI remains a major threat to public health.
AIMS
To assess the number and outcomes of patients hospitalized for acute MI in Poland in 2018 as well as proportions of patients participating in cardiac rehabilitation and undergoing invasive cardiac procedures following discharge.
METHODS
We used public databases. We included all patients hospitalized for acute MI in Poland in 2018 and assessed event-free survival along with uptake of invasive cardiac procedures, cardiac rehabilitation, and consultations with cardiologists.
RESULTS
A total of 75868 patients (mean age, 68.8 years) were hospitalized for acute MI in Poland in 2018 (the admission rate, 197.0 per 100000 inhabitants). In-hospital mortality was 8.4%, while one-year mortality was 17.3% (one-year post-discharge mortality was 9.8%). Approximately 75% and 96% of discharged patients consulted a general practitioner, whereas 12% and 62% consulted a cardiologist, 5% and 19% underwent percutaneous coronary intervention, 0.6% and 2.9% un-derwent coronary artery bypass grafting, while 0.04% and 1.9% had an implantable cardioverter defibrillator implanted within 30 days and 365 days following discharge. The participation rate in cardiac rehabilitation within the first 14 days following discharge was 11%, within the first 30 days was 19%, and within 365 days was 35%.
CONCLUSIONS
In-hospital and post-discharge mortality is still high in Poland. The access to cardiac consultations and cardiac rehabilitation following MI is insufficient. There is considerable potential for a further decrease in mortality in patients suffering from MI in Poland.

Identifiants

pubmed: 35188220
pii: VM/OJS/J/88637
doi: 10.33963/KP.a2022.0058
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

468-475

Auteurs

Piotr Jankowski (P)

Department of Internal Medicine and Geriatric Cardiology, Center of Postgraduate Medical Education, Warszawa, Poland. piotrjankowski@interia.pl.
Department of Epidemiology and Health Promotion, School of Public Health, Center of Postgraduate Medical Education, Warszawa, Poland. piotrjankowski@interia.pl.

Roman Topór-Mądry (R)

Agency for Health Technology Assessment and Tariff System, Warszawa, Poland.

Mariusz Gąsior (M)

3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.

Urszula Cegłowska (U)

Agency for Health Technology Assessment and Tariff System, Warszawa, Poland.

Marek Gierlotka (M)

Department of Cardiology, University Hospital, Institute of Medical Sciences, University of Opole, Poland.

Jacek Kubica (J)

Department of Cardiology and Internal Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.

Zbigniew Kalarus (Z)

Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Division of Medical Sciences in Zabrze, Silesian Medical University, Zabrze, Poland.

Maciej Lesiak (M)

1st Department of Cardiology, Poznań University of Medical Sciences, Poznań, Poland.

Wojciech Wojakowski (W)

Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.

Jacek Legutko (J)

Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.
John Paul II Hospital, Kraków, Poland.

Radosław Sierpiński (R)

Faculty of Medicine, Cardinal Stefan Wyszyński University, Warszawa, Poland.

Tomasz Zdrojewski (T)

epartment of Preventive Medicine and Education, Medical University of Gdansk, Gdańsk, Poland.

Jarosław Pinkas (J)

School of Public Health, Center of Postgraduate Medical Education, Warszawa, Poland.

Jarosław Kaźmierczak (J)

Department of Cardiology, Pomeranian Medical University, Szczecin, Poland.

Przemysław Mitkowski (P)

1st Department of Cardiology, Poznań University of Medical Sciences, Poznań, Poland.

Adam Witkowski (A)

Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warszawa, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH